Cytomegalovirus disease in immunocompetent adults
Authors: Enis D Kocak, Justin C Sherwin and Anthony J Hall
Published online: 4 May 2015
To the Editor: We read with interest the review by Lancini and colleagues on cytomegalovirus (CMV) in immunocompetent patients.1 This topic and its associations with ocular disease has garnered increased recognition in the eye care community.
Clinically, CMV can cause an anterior uveitis (iritis) or, more rarely, retinitis, in otherwise healthy patients.2 The uveitis typically features a chronic and/or recurrent course with anterior segment inflammation, keratic precipitates, endotheliitis, iris atrophy and elevated intraocular pressure (IOP).3 CMV retinitis is characterised by confluent or semiconfluent areas of retinal whitening with haemorrhage.4
As with systemic CMV disease, oral valganciclovir appears to be effective treatment for ocular disease.3-5 CMV-associated ocular disease in immunocompetent adults is underdiagnosed due to low clinical suspicion and its capacity to mimic inflammatory eye disease associated with other Herpesviridae such as herpes simplex virus or varicella zoster virus.3,5 Misdiagnosis as other Herpesviridae can result in antiviral treatment that is ineffective in CMV disease. Thus, CMV ocular disease should be considered as a differential diagnosis in immunocompetent patients presenting with chronic unilateral anterior uveitis or retinitis. Where suspected, an anterior and/or vitreous chamber paracentesis with viral polymerase chain reaction (PCR) analysis should be performed for definitive diagnosis.3
A recent case illustrates this diagnostic challenge. A 53-year-old immunocompetent and systemically well man presented with a unilateral chronic anterior uveitis and elevated IOP. Treatment with topical corticosteroid eyedrops was commenced for non-infectious uveitis. After a poor response, an anterior chamber paracentesis was performed, which tested positive for CMV (on PCR). The uveitis subsequently became quiescent with oral valganciclovir.
Competing interests
No relevant disclosures.
References
- Lancini D, Faddy HM, Flower R, et al. Cytomegalovirus disease in immunocompetent adults. Med J Aust 2014; 201: 578-580. 1
- Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008; 5: 47. 2
- Chee SP, Bacsal K, Jap A, et al. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 2008; 145: 834-840. 3
- Radwan A, Metzinger JL, Hinkle DM, et al. Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm 2013; 21: 324-328. 4
- van Boxtel LA, van der Lelij A, van der Meer J, et al. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 2007; 114: 1358-1362. lefthere
Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study
Andrew Palmer, Matthew Carter, Jeremy Yeo, Cecilia Shim, Jason Connor, Jeremy Hayllar, Gerald Holtmann, Naomi Moy, Elliott G. Playford, Naomi Runnegar, Paul J. Clark
The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention
Cyra Patel, Alexis Pillsbury, Tran Nguyen, Xia Wang, Helen E. Quinn, Clayton K. Chiu, Allen C. Cheng, Katie L. Flanagan, Zhicheng Wang
Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia
Jessica Howell, Lauren Andersson, Miriam T. Levy, James O'Beirne, Leon Adams, Katharine Irvine, Avik Majumdar, Golo Ahlenstiel, Kathy Jackson, Krispin Hajkowicz, Joseph Doyle, Jane Davies, Sarah Cherian, Wayne Dimech, Alexander J. Thompson
Localised Herpes Simplex Following Midline Laparotomy
Jessica S. Bulluss, Paul Chee, Matthew J. Verheyden
West Nile virus Kunjin subtype in rural NSW
Emily Gibson, Megan Whitley, Peter Murray, Linda Hueston, Jane Bennett, Raguharan Kathiresu, David N Durrheim
Differentiated and simplified oral HIV pre‐exposure prophylaxis (PrEP) models hold the key to virtually eliminating HIV transmission in Australia by 2030
Tyson Arapali, Sarah Warzywoda, Anthony K J Smith, Curtis Chan, Timothy R Broady, Erin Sullivan, Catherine MacPhail, Mohamed A Hammoud, Alexander Dowell‐Day, Benjamin R Bavinton